Neuropeptide AF (human)
Cat. No. 1928
Alternative Names: NPAF, Neuropeptide NPAF (human FMRFamide-related)
Biological ActivityEndogenous antiopioid peptide, implicated in pain modulation and endocrine functions. May also regulate metabolism via stimulation of β-adrenoceptor expression in adipocytes.
(Modifications: Phe-18 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Lefrere et al (2002) Neuropeptide AF and FF modulation of adipocyte metabolism. J.Biol.Chem. 277 39169. PMID: 12149260.
Elshourbagy et al (2000) Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J.Biol.Chem. 275 25965. PMID: 10851242.
Vilim et al (1999) Gene for pain modulatory neuropeptide FF: induction in spinal cord by noxious stimuli. Mol.Pharmacol. 55 804. PMID: 10220558.
If you know of a relevant reference for Neuropeptide AF (human) please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Neuropeptide AF (human) from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Neuropeptide AF (human), supplier, Implicated, pain, modulation, Anti-opioids, neuropeptides, FF, AF, NPFF, Receptors, Tocris Bioscience, Neuropeptide FF/AF Receptor products
Find multiple products by catalog number
New Products in this Area
Reverse analog of BradykininTASP 0390325
Potent and selective V1B receptor antagonist; orally bioavailableML 233
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonist
May 17 - 19, 2017